We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+28.51%
1 Year Est. Return
+77.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$31.8M
Cap. Flow
+$19.7M
Cap. Flow %
17.01%
Top 10 Hldgs %
43.17%
Holding
151
New
78
Increased
26
Reduced
12
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Financials 11.15%
3 Energy 9.32%
4 Communication Services 8.43%
5 Materials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHF icon
51
Brighthouse Financial
BHF
$3.63B
$523K 0.45%
+9,850
New +$481K
FWRD icon
52
CALL
Forward Air
FWRD
$466M
$515K 0.45%
+20,100
New +$578K
ABVX
53
Abivax
ABVX
$11.2B
$509K 0.44%
+6,000
New +$368K
PCAP
54
ProCap Acquisition Corp
PCAP
$327M
$486K 0.42%
+47,304
New +$488K
DRDB
55
Roman DBDR Acquisition Corp II
DRDB
$325M
$446K 0.39%
+43,200
New +$444K
MGRM
56
DELISTED
Monogram Orthopaedics
MGRM
$440K 0.38%
+75,000
New +$401K
NBIS
57
Nebius Group N.V.
NBIS
$47.7B
$438K 0.38%
3,900
OKUR
58
OnKure Therapeutics
OKUR
$164M
$428K 0.37%
155,490
+125,588
+420% +$311K
ODP
59
DELISTED
ODP
ODP
$427K 0.37%
+15,337
New +$315K
TDAY
60
USA Today Co
TDAY
$1.22B
$413K 0.36%
+100,000
New +$402K
GTERU
61
Globa Terra Acquisition Corp Units
GTERU
$158M
$411K 0.36%
+40,388
New +$410K
OACC
62
Oaktree Acquisition Corp III Life Sciences
OACC
$263M
$398K 0.34%
+37,827
New +$395K
MBAV
63
DELISTED
M3-Brigade Acquisition V Corp
MBAV
$382K 0.33%
+36,214
New +$387K
FDMT icon
64
4D Molecular Therapeutics
FDMT
$543M
$371K 0.32%
42,665
+29,665
+228% +$177K
LBTYK icon
65
Liberty Global Class C
LBTYK
$3.27B
$353K 0.31%
+30,000
New +$336K
CCIX
66
Churchill Capital Corp IX
CCIX
$399M
$348K 0.3%
+33,226
New +$350K
UNH icon
67
UnitedHealth
UNH
$379B
$345K 0.3%
+1,000
New +$302K
K
68
DELISTED
Kellanova
K
$328K 0.28%
4,000
+1,000
+33% +$79.5K
FERA
69
Fifth Era Acquisition Corp I
FERA
$326M
$315K 0.27%
+30,990
New +$315K
MLAC
70
DELISTED
Mountain Lake Acquisition Corp
MLAC
$309K 0.27%
+30,000
New +$308K
WW
71
WW International
WW
$138M
$301K 0.26%
+11,000
New +$378K
SRDX
72
DELISTED
Surmodics
SRDX
$299K 0.26%
+10,000
New +$334K
BRSL
73
Brightstar Lottery PLC
BRSL
$1.93B
$293K 0.25%
17,000
NKTR icon
74
Nektar Therapeutics
NKTR
$2.41B
$279K 0.24%
+4,895
New +$162K
STAA icon
75
STAAR Surgical
STAA
$1.14B
$269K 0.23%
+10,000
New +$238K

Similar funds

Rangeley Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Rangeley Capital held 151 positions worth $116M, up 38% from $83.8M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rangeley Capital deployed $19.7M of net new capital in Q3 2025, opening 78 new positions and adding to 26 existing holdings. Its largest new stake was Yext: 545,000 shares worth $4.64M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 47% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Delek US, an estimated $2.79M trimmed.

  • Rangeley Capital's largest Q3 2025 buy was Yext: 545,000 shares worth $4.64M.
  • Rangeley Capital added most to GSR III Acquisition Corp in Q3 2025, an estimated $941K increase.
  • Rangeley Capital's biggest Q3 2025 reduction was Delek US, cutting an estimated $2.79M.
  • Rangeley Capital fully exited Sage Therapeutics in Q3 2025, selling an estimated $6.66M.
  • Rangeley Capital's ten largest holdings make up 43% of its $116M portfolio in Q3 2025.
  • Rangeley Capital opened 78 new positions and closed 24 in Q3 2025.
  • Rangeley Capital's portfolio value rose 38% quarter-over-quarter to $116M.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.